NewslettersMammary Cell News Atossa Therapeutics Announces Plans to Pursue Metastatic Breast Cancer Indication for (Z)-Endoxifen and Continued Engagement with FDA on Additional Indications By Jamie Kang - March 13, 2025 0 29 Atossa Therapeutics, Inc. announced its strategic decision to pursue a metastatic breast cancer indication for (Z)-endoxifen. [Atossa Therapeutics, Inc.] Press Release